Pharmaceuticals APAC News & Press Release Distribution

Pharmaceuticals

All
Global

Dr Ivan Puah Recommends Fat Grafting As A Solution Following Post-surgery Scars or Disfigurement

Fat grafting is highly recommended as part of the corrective surgery method to correct facial or body disfigurement from liposuction, laparoscopy or surgeries that cause dents and irregular contours. SINGAPORE, Aug. 2, 2022 /PRNewswire/ -- Dr Ivan Puah, Medical Director at Amaris B. Clinic,...

2022-08-02 16:41 2079

Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency

Implemented by the Centers for Disease Control and Prevention, the diagnosis code will accurately identify US patients with APDS, supporting care and research efforts LEIDEN, Netherlands, Aug. 2, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Na...

2022-08-02 13:00 2036

GenKOre develops hypercompact adenine base editors (ABEs)

DAEJEON, South Korea, Aug. 2, 2022 /PRNewswire/ -- GenKOre, a biotech start-up in Korea, succeeded in the development of ABEs based on its own hypercompact gene-editing technology and had the relevant study published on Nature Chemical Biology onAugust 2, 2022.

2022-08-02 09:07 2042

GenKOre develops hypercompact adenine base editors (ABEs)

AVer Introduces Revolutionary Detachable Medical Grade Cameras

NEW TAIPEI CITY, Taiwan, Aug. 2, 2022 /PRNewswire/ -- AVer Information Inc., the award-winning provider of video collaboration and education technology solutions, is excited to introduce its Connected Health Solutions, which was created from AVer's dedication in understanding and contributing to ...

2022-08-02 09:00 1869

Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations

CAMBRIDGE, Mass. and SUZHOU, China, Aug. 2, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced the appointment ofAngela (Hui) Yan as President of China and Asi...

2022-08-02 07:00 2619

Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations

Telix APAC Report: Regulatory Progress for Prostate and Kidney Cancer Imaging

MELBOURNE, Australia, Aug. 2, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports on regulatory progress for the Company's core prostate and kidney cancer imaging programs in theAsia Pacific (APAC) Operating Region, including progress in the major marke...

2022-08-02 06:54 1912

Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the Treatment of Rare Immunodeficiency, APDS

EMA accelerated assessment allows a shorter review period for leniolisib from a standard 210 days to 150 days Pharming is on track to submit its Marketing Authorisation Application for leniolisib in H2 2022 LEIDEN, the Netherlands, Aug. 1, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or...

2022-08-01 13:00 2315

Alps Pharmaceutical confirms through human pharmacokinetic studies that its newly developed natural quercetin formulation can significantly reduce quercetin usage

HIDA, Japan, Aug. 1, 2022 /PRNewswire/ -- On Aug 02, 2022, with the recent surge in raw material prices and the continued scarcity of quercetin in the market, Alps Pharmaceutical Ind. Co., Ltd. (Hida,Japan, President: Osamu Ushimaru) announced that it has confirmed through human pharmacokinetic s...

2022-08-01 12:28 1446

CHEMICAL INDUSTRIES (FAR EAST) LIMITED MARKS 60TH ANNIVERSARY WITH $60,000 DONATION TO SOULJOURN

SINGAPORE, Aug. 1, 2022 /PRNewswire/ -- Founded in 1962, Chemical Industries (Far East) Limited (CIL) commemorated its 60th anniversary with a dinner for employees, customers and business partners at The Capitol Kempinski Hotel on 29 th July 2022. As part of its commemoration, CIL made a $60,000 d...

2022-08-01 10:40 2671

CHEMICAL INDUSTRIES (FAR EAST) LIMITED MARKS 60TH ANNIVERSARY WITH $60,000 DONATION TO SOULJOURN

Innovent and Laekna Jointly Announce First Patient Dosed with Three-drug Combination in a Phase 1/2 Study for the Treatment of Patients with Solid Tumors Who Were Resistant to Prior Anti-PD-1/PD-L1 Therapy

SAN FRANCISCO and SUZHOU, China, Aug. 1, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and ot...

2022-08-01 08:00 2324

EuroEyes signs tri-party agreement of mutual cooperation with leading medical universities in the PRC and Germany

Collaboration aims to drive innovation and nurture talent that could help power sustainable business growth for the company HONG KONG, July 29, 2022 /PRNewswire/ -- EuroEyes International Eye Clinic Limited ("EuroEyes" or the "Company", together with its subsidiaries, the "Group", HKEX: 1846) an...

2022-07-29 20:14 1850

Seegene unveils strategies for global expansion at 2022 AACC

Company has taken part in the Annual Scientific Meeting & Clinical Lab Expo since 2007 This year's event showcased its In-life PCR campaign and STARlet-AIOS Seegene also displayed Novaplex™ assays, including a test for detecting the monkeypox virus SEOUL, South Korea, July 29, 2022 /PRNewswire/...

2022-07-29 19:00 2828

EuroEyes signs tri-party agreement of mutual cooperation with leading medical universities in the PRC and Germany

Collaboration aims to drive innovation and nurture talent that could help power sustainable business growth for the company Hong Kong, July 29, 2022 /PRNewswire/ -- EuroEyes International Eye Clinic Limited ("EuroEyes" or the "Company", together with its subsidiaries, the "Group", HKEX: 1846) an...

2022-07-29 18:43 3183

EuroEyes signs tri-party agreement of mutual cooperation with leading medical universities in the PRC and Germany

As part of 'Operation Nasal Vaccine' to counter COVID-19 spread, ACM-001 booster vaccine administered to first subject in phase 1 safety and immunogenicity trial

SINGAPORE and BASEL, Switzerland and SYDNEY, July 29, 2022 /PRNewswire/ -- ACM Biolabs , a biotechnology company with operations in Singapore, Switzerland and Australia, focusing on the development of next generation vaccines for infectious diseases, personalized immunoth...

2022-07-29 16:00 2059

Lynk Pharmaceuticals Announces the First Participant Dosed in Phase I Trial of LNK01004

HANGZHOU, China, July 29, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has completed dosing the first participant in the phase I clinical study inChina for its self-developed, in...

2022-07-29 10:00 3214

Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target

The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050 SINGAPORE, July 29, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first g...

2022-07-29 09:24 3441

Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target

Kira Pharmaceuticals Receives FDA Orphan Drug Designation for KP104, a Bifunctional Antibody Fusion Protein, for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

CAMBRIDGE, Mass. and SUZHOU, China, July 28, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Or...

2022-07-28 19:00 1928

The Clinician and Clalit Health Services partner to drive value-based care and digital care pathway implementation in Israel

AUCKLAND, New Zealand and TEL AVIV, Israel, July 28, 2022 /PRNewswire/ -- The Clinician , a global digital health innovator, has partnered with one of the largest HMOs in the world andIsrael's largest healthcare organization, Clalit Health Services, through it's inn...

2022-07-28 12:33 2009

Transcenta to Present Interim Safety and Efficacy Data of the TST001 and Chemotherapy Combination Expansion Cohort for Claudin18.2 Positive First Line Gastric Cancer at ESMO Congress 2022

SUZHOU, China, July 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that the interim safe...

2022-07-28 08:00 1835

BAMF Health and Telix complete first total-body PET scans with Illuccix for prostate cancer imaging

Telix and BAMF Health use Illuccix® (kit for the preparation of Gallium Ga 68 gozetotide injection) for the first time with uEXPLORER® total-body PET scanner for prostate cancer imaging GRAND RAPIDS, Mich. and INDIANAPOLIS, July 27, 2022 /PRNewswire/ -- The PSMA-PET[1] imaging agent Illuccix® fr...

2022-07-27 20:30 2220

1 ... 66 67 686970 71 72 ... 181